GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

Reported 12 months ago

Writing summary...

Source: WSJ

View details

You may also interested in these wikis

OpenAI Utilizes Google's AI Chips for Its Products
Nike Stock Jumps 15% Amidst Tariff Challenges and Sales Forecasts
Week in Review: Meta Aggressively Expands AI Team
Fireworks Set to Dazzle This Fourth of July, but Future Celebrations Might Face Hurdles
Last-minute Changes Increase Cost of Trump's 'Big, Beautiful Bill'
Weakening US Consumer Spending Signals Economic Concerns
Jim Cramer Defends Amgen’s Stock Amid Market Sell-off
Tech Rally Extends Beyond Magnificent Seven
Citi Increases Alphabet's Price Target Following Strong YouTube and Search Performance
Goldman Sachs Abandons Hotel Development Plans in Greece
Back to all Wikis